(Gln22, Asn23) -Amyloid β-Protein (1-40)
The (Gln22, Asn23) -Amyloid β-Protein (1-40) peptide is a research tool for investigating mutations linked to cerebral amyloid angiopathy. It supports in vitro studies of amyloid aggregation kinetics and in vivo models of cerebrovascular amyloid deposition and associated neurotoxicity.
Product Specifications
Field of Research
Neuroscience
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog